Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Double-blind, Study to Evaluate the Eosinophils Activation Parameters and Phagocyte Function in Patients With Persistent Asthma Treated With Montelukast

NCT00770900 is registered in ClinicalTrials.gov with University of Brasilia as lead sponsor.

NCT NCT00770900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Double-blind, Study to Evaluate the Eosinophils Activation Parameters and Phagocyte Function in Patients With Persistent Asthma Treated With Montelukast
Lead sponsor
University of Brasilia
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2008
Completion date
December 31, 2009
Enrollment
83 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma